Skip to main content

ADVERTISEMENT

Podcasts

OUTSPOKEN ONCOLOGY
05/03/2022
Carla Tardif, CEO of Family Reach, discusses the personal expenses that patients with cancer and their families are burdened with aside from medical care as well as the ways in which Family Reach is offering financial support for these...
Carla Tardif, CEO of Family Reach, discusses the personal expenses that patients with cancer and their families are burdened with aside from medical care as well as the ways in which Family Reach is offering financial support for these...
Carla Tardif, CEO of Family...
05/03/2022
Journal of Clinical Pathways
Outspoken Oncology
OUTSPOKEN ONCOLOGY
05/03/2022
Anita Gruninger, RN and certified case manager, provides the often-forgotten perspective of a caregiver, including the emotional and financial toll a cancer diagnosis has on patients and their caregivers as well as the struggles of navigating...
Anita Gruninger, RN and certified case manager, provides the often-forgotten perspective of a caregiver, including the emotional and financial toll a cancer diagnosis has on patients and their caregivers as well as the struggles of navigating...
Anita Gruninger, RN and...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Toni Choueiri, MD, discusses surgical considerations and multidisciplinary care for localized kidney cancer, adjuvant therapies largely falling short of expectations, and the plethora of frontline therapies available in metastatic disease.
Toni Choueiri, MD, discusses surgical considerations and multidisciplinary care for localized kidney cancer, adjuvant therapies largely falling short of expectations, and the plethora of frontline therapies available in metastatic disease.
Toni Choueiri, MD, discusses...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Aaron Gerds, MD, department of hematology and medical oncology, Cleveland Clinic, describes the benefits and pitfalls of Twitter as a platform for doctors to share their ideas and engage in the "ultimate peer-review process."
Aaron Gerds, MD, department of hematology and medical oncology, Cleveland Clinic, describes the benefits and pitfalls of Twitter as a platform for doctors to share their ideas and engage in the "ultimate peer-review process."
Aaron Gerds, MD, department of...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Ishwaria Subbiah, MD, MS, explains the value of having a dedicated team for oncology patient symptom management and demonstrates how using “supportive care” rather than “palliative care” can impact referrals.
Ishwaria Subbiah, MD, MS, explains the value of having a dedicated team for oncology patient symptom management and demonstrates how using “supportive care” rather than “palliative care” can impact referrals.
Ishwaria Subbiah, MD, MS,...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
At the Oncology Clinical Pathways Congress, Chadi sat down with a host of experts to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.
At the Oncology Clinical Pathways Congress, Chadi sat down with a host of experts to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.
At the Oncology Clinical...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Chadi picks the brain of Sayed Tabatabai, MD, a full-time nephrologist and avid writer that attempts to humanize and beautify the patient experience through a variety of written anecdotes in Twitter threads and short stories.
Chadi picks the brain of Sayed Tabatabai, MD, a full-time nephrologist and avid writer that attempts to humanize and beautify the patient experience through a variety of written anecdotes in Twitter threads and short stories.
Chadi picks the brain of Sayed...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Chadi makes his rounds at the Oncology Clinical Pathways Congress, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback.
Chadi makes his rounds at the Oncology Clinical Pathways Congress, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback.
Chadi makes his rounds at the...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Bobby Daly, MD, MBA, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between...
Bobby Daly, MD, MBA, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between...
Bobby Daly, MD, MBA, breaks down...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in...
Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in...
Vincent DeVita, MD, professor of...
05/03/2022
Journal of Clinical Pathways